OBAGI Medical (OMPI) Posts Q3 EPS of $0.14, In-Line with Street; Guides
More News related to OMPI
- Canaccord Adams Maintains a 'Buy' on Obagi Medical Products (OMPI); Raises PT
- OBAGI Medical (OMPI) Posts Q3 EPS of $0.14, In-Line with Street; Guides
- Obagi Medical Products Reports Third Quarter 2009 Earnings
- Trading Radar for 11/05: Starbucks (SBUX), CBS Corp. (CBS), CVS (CVS), Toyota (TM), Thomson Reuters (TRI)
- Obagi Medical Products to Report Third Quarter 2009 Financial Results and Host a Conference Call on November 5, 2009
OBAGI Medical Products INC (NASDAQ: OMPI) reports Q3 EPS of $0.14, even with the analyst estimate of $0.14. Revenue for the quarter was $24.9 million, which compares to the estimate of $25.49 million.
Sees Q4 EPS of $0.16 - $0.18, versus $0.16 consensus.
Related Categories
EarningsGuidance
Stocks Mentioned
+0.02Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
